Despite raising $1B over past 5 years, ElevateBio lets go of 17% of workforce
Cell- and gene-therapy-focused ElevateBio has let go of 17% of staffers as part of the company’s second layoff round since raising $401 million nearly two years ago.
Cell- and gene-therapy-focused ElevateBio has let go of 17% of staffers as part of the company’s second layoff round since raising $401 million nearly two years ago.
